News - Senju Pharmaceutical

Filter

Current filters:

Senju Pharmaceutical

Popular Filters

ISTA Pharma accepts $500 million bid from Bausch & Lomb; settles royalty dispute

27-03-2012

US ophthalmic drugmaker ISTA Pharmaceuticals (Nasdaq: ISTA), which rejected a hostile takeover bid from…

Bausch & LombBromdayISTA PharmaceuticalLicensingMergers & AcquisitionsOphthalmicsPharmaceuticalProlensaSenju PharmaceuticalXibrom

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top